Response from the Platform for ACT-A Civil Society & Community Representatives to the Berlin declaration (Biopharmaceutical industry vision for equitable access in pandemics)
In response to the Berlin declaration released by the IFPMA (International Federation of Pharmaceutical Manufacturers & Associations) on 19 July, setting out the “Biopharmaceutical industry vision for equitable access in pandemics”, civil society and
Call for Nominations: Global COVID Communities Board
The Platform is currently inviting applications to the Global COVID Communities Board. This process is designed to engage up to a maximum of 20 individuals from communities directly affected by COVID, including living with Long
The Case for CSO Representation on the Financial Intermediary Fund for PPR
The Case for CSO Representation on the Financial Intermediary Fund for PPR White Paper for Discussion at the World Bank Board on Thursday, 30th June 2022 Executive Summary CSOs bring essential catalytic technical expertise,
Statement on World Trade Organization’s 12th Ministerial Conference (June 2022)
Following the Ministerial Decision adopted at the World Trade Organization's 12th Ministerial Conference (MC12) held from 12-17 June 2022, the Platform for ACT-A Civil Society and Communities has issued a statement which can be found
Platform for ACT-A Civil Society and Community Representatives Evaluation
The Platform for ACT-A Civil Society and Community Representatives (co-hosted by WACI Health, Global Fund Advocates Network (GFAN) and STOPAIDS) is currently coordinating an evaluation of its work to: Identify the successes and challenges of
Statement on the ACT-A independent evaluation (May 2022)
At the 10th meeting of the ACT-A Facilitation Council (26 April 2022), the Co-Chairs (South Africa and Norway) shared their plan to initiate an independent evaluation of ACT-A and its successes and challenges. The Platform
